Literature DB >> 15673582

Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdom.

Kristina Secnik1, Louis S Matza, Suzi Cottrell, Eric Edgell, Dominic Tilden, Sally Mannix.   

Abstract

OBJECTIVES: The purpose of this study was to use standard gamble (SG) utility interviews to assess parent preferences for health states of childhood attention-deficit/hyperactivity disorder (ADHD).
METHODS: The study was conducted in August 2003 in London, England. Parents (N=83) of children diagnosed with ADHD completed SG utility interviews, rating their child's current health and 14 hypothetical health states describing untreated ADHD and ADHD treated with a nonstimulant, immediate-release stimulant, or extended-release stimulant. Raw temporary utilities ranging from 0 (worst health) to 1 (best health) were adjusted to a chronic utility scale ranging from 0 (death) to 1 (best health) using a linear transformation. Parents rated the severity of their children's ADHD symptoms using the Attention-Deficit/Hyperactivity Disorder Rating Scale-IV (ADHD-RS) and their children's health-related quality of life using the EuroQol EQ-5D.
RESULTS: Raw and adjusted SG ratings of hypothetical health states ranged from 0.63-0.90 and 0.88-0.96, respectively. Parents' raw SG scores of their child's current health state (mean=0.72) were significantly correlated with inattentive, hyperactive, and overall ADHD symptoms (r=-0.25, -0.27, -0.27; P <0.05) and the EQ-5D visual analogue scale (r=0.26; P <0.05).
CONCLUSION: This UK-based study suggests that parent SG interviews are a valid method for obtaining utilities for child ADHD-related health states. The utilities obtained in this study would be appropriate for use in a cost-utility analysis evaluating the costs and benefits of childhood ADHD treatments in the United Kingdom.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15673582     DOI: 10.1177/0272989X04273140

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  28 in total

Review 1.  Systematic Review of Patients' and Parents' Preferences for ADHD Treatment Options and Processes of Care.

Authors:  Nicole K Schatz; Gregory A Fabiano; Charles E Cunningham; Susan dosReis; Daniel A Waschbusch; Stephanie Jerome; Kellina Lupas; Karen L Morris
Journal:  Patient       Date:  2015-12       Impact factor: 3.883

2.  Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe.

Authors:  Karine Chevreul; Morgane Michel; Karen Berg Brigham; Julio López-Bastida; Renata Linertová; Juan Oliva-Moreno; Pedro Serrano-Aguilar; Manuel Posada-de-la-Paz; Domenica Taruscio; Arrigo Schieppati; Georgi Iskrov; Márta Péntek; Johann Matthias Graf von der Schulenburg; Panos Kanavos; Ulf Persson; Giovani Fattore
Journal:  Eur J Health Econ       Date:  2016-04-08

Review 3.  The impact of medications on quality of life in attention-deficit hyperactivity disorder: a systematic review.

Authors:  David Coghill
Journal:  CNS Drugs       Date:  2010-10       Impact factor: 5.749

Review 4.  Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.

Authors:  Eric Q Wu; Paul Hodgkins; Rym Ben-Hamadi; Juliana Setyawan; Jipan Xie; Vanja Sikirica; Ella X Du; Sherry Y Yan; M Haim Erder
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

5.  Utilities and disutilities for attributes of injectable treatments for type 2 diabetes.

Authors:  Kristina S Boye; Louis S Matza; Kimberly N Walter; Kate Van Brunt; Andrew C Palsgrove; Aodan Tynan
Journal:  Eur J Health Econ       Date:  2010-03-12

6.  Examining Parents' Preferences for Group and Individual Parent Training for Children with ADHD Symptoms.

Authors:  Frances A Wymbs; Charles E Cunningham; Yvonne Chen; Heather M Rimas; Ken Deal; Daniel A Waschbusch; William E Pelham
Journal:  J Clin Child Adolesc Psychol       Date:  2015-02-20

7.  A discrete choice conjoint experiment to evaluate parent preferences for treatment of young, medication naive children with ADHD.

Authors:  Daniel A Waschbusch; Charles E Cunningham; William E Pelham; Heather L Rimas; Andrew R Greiner; Elizabeth M Gnagy; James Waxmonsky; Gregory A Fabiano; Jessica A Robb; Lisa Burrows-Maclean; Mindy Scime; Martin T Hoffman
Journal:  J Clin Child Adolesc Psychol       Date:  2011

8.  Caregiver Treatment Preferences for Children with a New Versus Existing Attention-Deficit/Hyperactivity Disorder Diagnosis.

Authors:  Susan dosReis; Alex Park; Xinyi Ng; Emily Frosch; Gloria Reeves; Charles Cunningham; Ellen M Janssen; John F P Bridges
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-12-19       Impact factor: 2.576

9.  Prevalence and Losses in Quality-Adjusted Life Years of Child Health Conditions: A Burden of Disease Analysis.

Authors:  Benjamin M Craig; John D Hartman; Michelle A Owens; Derek S Brown
Journal:  Matern Child Health J       Date:  2016-04

10.  Long-acting methylphenidate-OROS in youths with attention-deficit hyperactivity disorder suboptimally controlled with immediate-release methylphenidate: a study of cost effectiveness in The Netherlands.

Authors:  Adrianne Faber; Michel van Agthoven; Luuk J Kalverdijk; Hilde Tobi; Lolkje T W de Jong-van den Berg; Lieven Annemans; Maarten J Postma
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.